Multimorbidity, mortality, and HbA1c in type 2 diabetes: A cohort study with UK and Taiwanese cohorts.
Jason I ChiangPeter HanlonTsai-Chung LiBhautesh Dinesh JaniJo-Anne E Manski-NankervisJohn FurlerCheng-Chieh LinShing-Yu YangBarbara I NichollSharmala ThuraisingamFrances S MairPublished in: PLoS medicine (2020)
Multimorbidity patterns associated with the highest mortality differed between UK Biobank (a population predominantly comprising people of European descent) and the Taiwan NDCMP, a predominantly ethnic Chinese population. Future research should explore the mechanisms underpinning the observed relationship between increasing multimorbidity count and reduced HbA1c alongside increased mortality in people with T2D and further examine the implications of different patterns of multimorbidity across different ethnic groups. Better understanding of these issues, especially effects of condition type, will enable more effective personalisation of care.